Amanda Smith has kicked insulin to the curb in what experts are calling a milestone in the fight against Type 1 diabetes.

Swiss company PharmaSens and SiBionics have entered a development partnership for niia signature, an all-in-one wearable that ...

Children with diabetes who inhaled their mealtime doses of insulin did just as well as those who injected insulin under the ...

Most in a small group of patients receiving a stem cell-based infusion no longer needed insulin, but the drug may not suit ...

A fast-growing group of Americans are turning to what many call the "gray market" for obesity medicines, bringing cheap ...

We’re on track to develop the first-ever FDA-approved drug for longevity – for any species,” Celine Halioua told The Post.

Tsimikas, vice president of San Diego’s Scripps Whittier Diabetes Institute, helped deliver positive news for the estimated 7 million Americans who take insulin every day to manage their type 2 ...

Food and Drug Administration Commissioner Marty Makary said the agency ... panel alarms pediatricians with inquiries into long-settled questions Long-lasting insulin takes another step forward with ...

The chief product and customer experience officer said Insulet has seen an uptick in users with Type 2 diabetes since ...

A novel weight loss drug in the same class as semaglutide has successfully met its targets in its largest clinical trial yet, ...

New study results demonstrated the safety and efficacy of the MannKind Afrezza inhaled insulin offering for children with ...

While many systems already pair continuous glucose monitors (CGMs) and insulin pumps, PharmaSens and SiBionics may have ...